Newswise — Press conferences will be held twice-daily October 23-25 at the Cardiovascular Research Foundation's (CRF) eighteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C. to announce late-breaking results from clinical trials.

MONDAY, OCTOBER 23, 9:30 " 10:30 a.m.Findings from the LONG-DES-II, NORDIC BIFURCATION and ZOMAXX-I studies of current and new drug-eluting stents in complicated heart blockages, and patients with heart disease.

MONDAY, OCTOBER 23, 2:00 " 3:00 p.m.Results from the MEDISTRA, THUNDER, FAST LANE, DESCover and other studies of drug-eluting stents, drug-coated angioplasty balloons, and the impact of diabetes medication on blood vessels in non-diabetic patients.

TUESDAY, OCTOBER 24, 9:30 " 10:30 a.m.Outcomes from the HAAMU-STENT, ACUITY PCI, and CIAO studies of drug-eluting stents used for patients with heart attack and different medications used to make stent procedures safe in patients with heart problems.

TUESDAY, OCTOBER 24, 2:00 " 3:00 p.m.Findings from the NOBORI 1, BEST, ETHOS 1, VAMPIRE and ABSORB studies of new types of drug-eluting stents, first-in-human use of a bioabsorbable stent, first-in-human use of a bioabsorbable heart-defect closure device, and plaque debris removal in heart attack.

TUESDAY, OCTOBER 24, 3:30 " 4:00 p.m.SPECIAL PRESS CONFERENCE at which six experts from four nations will provide perspective on recently-presented, widely publicized research questioning the long-term safety and efficacy of drug-eluting stents. This Q&A session provides the opportunity to interact with panelists from a special Stent Thrombosis Hot Line Session that will be conducted Tuesday, October 23, 12:45 " 1:45 p.m.

WEDNESDAY, OCTOBER 25, 9:30 " 10:30 a.m.Results from the SORT OUT II, REPAIR MI LATE, ICON and CARE studies of drug-eluting stents, bone marrow stem cells in patients with recent heart attack, and the risks of kidney problems with three popular contrast agents used in the imaging of heart patients.

WEDNESDAY, OCTOBER 25, 2:00 " 3:00 p.m.Outcomes from the TAXUS ATLAS, STENT-MULTIVESSEL, TAXUS OLYMPIA, RESOLUTE and REWARD studies of current and new drug-eluting stents in every-day and complex heart disease cases.

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

Cardiovascular Research Foundation's (CRF) 18th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium